Background: Mediastinal staging is crucial to determine the prognosis and treatment options
for patients with non-small cell lung cancer (NSCLC). In this study, we compared the results …

Accurate assessment of mediastinal lymph node involvement in patients with non-small-cell
lung cancer (NSCLC) is necessary to select patients for direct surgical treatment. The aims …

Study objective To compare the performance of CT, radio-labeled 18 F-fluoro-2-deoxy-D-
glucose positron emission tomography (FDG-PET) blinded to CT, and FDG-PET visually …

Integrated positron emission tomography (PET)/CT is routinely used for mediastinal nodal
staging of non-small cell lung carcinoma in centers throughout the world. This modality is the …

Objective: Mediastinal lymph node staging determines the treatment strategy for non-small-
cell lung cancer. This study aims to evaluate prospectively the accuracy of preoperative …

Introduction Patients with non-small cell lung cancer (NSCLC) require careful preoperative
staging to define resectability for potential cure. 18 Fluorodeoxyglucose positron emission …

Positron emission tomography (PET) is a modality that differentiates malignant from benign
processes based upon metabolism rather than anatomy. A number of studies have …

OBJECTIVE: The involvement of mediastinal lymph nodes is a very important prognostic
factor in patients with potentially resectable non–small cell lung cancer. Our aim in this study …

As lymph node metastasis is the most important factor determining the surgical outcome of
lung cancer, we evaluated the accuracy and clinical usefulness of functional imaging with …

1740 Objectives: Aim: The role of FDG-PET in the staging of the mediastinum in patients with
NSCLC is still under discussion. Several studies have shown a high negative predictive …